Chlordiazepoxide + Clidinium
Composition
This formulation contain combination of Chlordiazepoxide and Clidinium as active agents
Indications
irritable bowel syndrome (IBS), including abdominal pain, cramps, bloating, and diarrhea.
Side effects
drowsiness, dizziness, dry mouth, constipation, blurred vision, and urinary retention
Precautions
Caution should be exercised in patients with a history of substance abuse, depression, or respiratory disorders.
Contraindications
should also be avoided in patients with glaucoma, myasthenia gravis, or urinary retention.
Dosage and administration
directed by a healthcare professional
Countries
Available Forms
Tablet, Capsule
Manufacturing Services
Third Party Manufacturing Company WHO, GMP, EUGMP, USFDA, In India | Contract Manufacturing Organization (CMO) WHO, GMP, EUGMP, USFDA Services in India, Mumbai, Navi Mumbai| Contract Development and Manufacturing Organization (CDMO) WHO, GMP, EUGMP, USFDA - Services in India | Pharmaceutical Contract Manufacturing Company WHO, GMP, EUGMP, USFDA in Navi Mumbai, India | Top Pharmaceutical Product Exporters, Suppliers, Distributer WHO, GMP, EUGMP, USFDA in Mumbai